Virology, Immunology and Microbiology, Microbiology (medical), Structural Biology
512
Scholar Citations
11
Scholar h-index
12
Scholar i10-index
RECENT SCHOLAR PUBLICATIONS
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants L Dépéry, I Bally, A Amen, B Nemoz, M Buisson, L Grossi, A Truffot, ... Microbiology Spectrum 13 (1) , 2025 2025 Citations: 8
Longitudinal high-throughput single-B-cell exploration of the broadly neutralizing antibody repertoire in an HIV-1 elite-neutralizer B Nemoz Université Grenoble Alpes [2020-....] , 2024 2024
Risk factors for nosocomial COVID-19 in a French university hospital C Dinh, M Gallouche, H Terrisse, K Gam, C Giner, B Nemoz, S Larrat, ... Infectious Diseases Now 53 (5), 104695 , 2023 2023 Citations: 5
The onset of late severe lung impairment in COVID-19 is associated with high inflammation markers at admission and metabolic syndrome markers O Epaulard, A Le Gouellec, M Le Marechal, B Nemoz, AL Borel, ... medRxiv, 2022.12. 20.22282909 , 2022 2022
Use of RT-PCR thermocycling program for the quantification of DNA viruses in a single run with RNA viruses: example of Altona RealStar® HSV or VZV PCR kits J Andreani, J Lupo, B Nemoz, A Truffot, S Larrat, P Morand, R Germi Infectious Diseases Now , 2022 2022 Citations: 1
Risk factors of nosocomial Covid-19 in a French university hospital: a case-control study C Dinh, M Gallouche, H Terrisse, K Gam, C Giner, B Nemoz, S Larrat, ... 2022 Citations: 1
COVID-19 geographical maps and clinical data warehouse PREDIMED S Artemova, A Caporossi, C Cancé, PE Madiot, B Nemoz, S Larrat, ... MEDINFO 2021: One World, One Health–Global Partnership for Digital … , 2022 2022 Citations: 2
Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: influence of initial severity and steroid use O Epaulard, M Buisson, B Nemoz, M Le Maréchal, N Terzi, JF Payen, ... The Journal of Infection 84 (3), 418 , 2021 2021 Citations: 11
Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management? J Andreani, J Lupo, R Germi, C Laugier, M Roccon, S Larrat, P Morand, ... Journal of Clinical Virology 143, 104947 , 2021 2021 Citations: 14
SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study A Landoas, F Cazzorla, M Gallouche, S Larrat, B Nemoz, C Giner, ... Antimicrobial Resistance & Infection Control 10 (1), 114 , 2021 2021 Citations: 24
Measles-associated pneumonia in an immunocompromised patient: Persistent shortcomings in vaccination guidelines A Portais, M Le Marechal, B Nemoz, A Dartevel, G Rigault, P Pavese, ... Infectious Diseases Now 51 (3), 316-318 , 2021 2021 Citations: 2
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y. V1 (B. 1.1. 7, variant of concern 202012/01) in France, January to March 2021 A Gaymard, P Bosetti, A Feri, G Destras, V Enouf, A Andronico, S Burrel, ... Eurosurveillance 26 (9), 2100133 , 2021 2021 Citations: 86
Teaching NeuroImages: sARS-CoV-2–related encephalitis: MRI pattern of olfactory tract involvement O Casez, G Willaume, S Grand, B Nemoz, J Lupo, P Kahane, JP Brion Neurology 96 (4), e645-e646 , 2021 2021 Citations: 36
COVID-19 in clinical practice: A narrative synthesis M Le Marechal, P Morand, O Epaulard, B Nemoz Medecine et Maladies Infectieuses 50 (8), 639-647 , 2020 2020 Citations: 7
Guillain-Barré syndrome related to SARS-CoV-2 infection K Bigaut, M Mallaret, S Baloglu, B Nemoz, P Morand, F Baicry, A Godon, ... Neurology: Neuroimmunology & Neuroinflammation 7 (5), e785 , 2020 2020 Citations: 144
Norcarfentanil: carfentanil misuse or remifentanil treatment? N Allibe, N Fouilhe Sam-Lai, T Willeman, JF Jourdil, M Bartoli, M Mallaret, ... Forensic Toxicology 37 (2), 488-495 , 2019 2019 Citations: 17
Development of a panmicrobial metagenomic analysis of capture-enriched specimens for the caracterization of lung microbiota in cystic fibrosis patients B Némoz < bound method Organization. get_name_with_acronym of< Organization: DUMAS … , 2019 2019
New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases B Nemoz, D Ternant, S Bailly, E Gautier‐Veyret, JF Jourdil, B Bonaz, ... British Journal of Clinical Pharmacology 85 (4), 722-728 , 2019 2019 Citations: 10
Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study T Semenova, B Nemoz, V Thibault, G Lagathu, G Duverlie, E Brochot, ... Epidemiology & Infection 147, e234 , 2019 2019 Citations: 11
Simultaneous quantification of adalimumab and infliximab in human plasma by liquid chromatography–tandem mass spectrometry JF Jourdil, B Némoz, E Gautier-Veyret, C Romero, F Stanke-Labesque Therapeutic Drug Monitoring 40 (4), 417-424 , 2018 2018 Citations: 26
MOST CITED SCHOLAR PUBLICATIONS
Guillain-Barré syndrome related to SARS-CoV-2 infection K Bigaut, M Mallaret, S Baloglu, B Nemoz, P Morand, F Baicry, A Godon, ... Neurology: Neuroimmunology & Neuroinflammation 7 (5), e785 , 2020 2020 Citations: 144
Mapping of potent and specific binding motifs, GLOGEN and GVOGEA, for integrin α1β1 using collagen toolkits II and III SW Hamaia, N Pugh, N Raynal, B Némoz, R Stone, D Gullberg, D Bihan, ... Journal of Biological Chemistry 287 (31), 26019-26028 , 2012 2012 Citations: 90
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y. V1 (B. 1.1. 7, variant of concern 202012/01) in France, January to March 2021 A Gaymard, P Bosetti, A Feri, G Destras, V Enouf, A Andronico, S Burrel, ... Eurosurveillance 26 (9), 2100133 , 2021 2021 Citations: 86
Teaching NeuroImages: sARS-CoV-2–related encephalitis: MRI pattern of olfactory tract involvement O Casez, G Willaume, S Grand, B Nemoz, J Lupo, P Kahane, JP Brion Neurology 96 (4), e645-e646 , 2021 2021 Citations: 36
Simultaneous quantification of adalimumab and infliximab in human plasma by liquid chromatography–tandem mass spectrometry JF Jourdil, B Némoz, E Gautier-Veyret, C Romero, F Stanke-Labesque Therapeutic Drug Monitoring 40 (4), 417-424 , 2018 2018 Citations: 26
SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study A Landoas, F Cazzorla, M Gallouche, S Larrat, B Nemoz, C Giner, ... Antimicrobial Resistance & Infection Control 10 (1), 114 , 2021 2021 Citations: 24
Norcarfentanil: carfentanil misuse or remifentanil treatment? N Allibe, N Fouilhe Sam-Lai, T Willeman, JF Jourdil, M Bartoli, M Mallaret, ... Forensic Toxicology 37 (2), 488-495 , 2019 2019 Citations: 17
Evaluation of the cobas ® GT hepatitis C virus genotyping assay in G1-6 viruses including low viral loads and LiPA failures B Némoz, L Roger, V Leroy, JD Poveda, P Morand, S Larrat Plos one 13 (3), e0194396 , 2018 2018 Citations: 15
Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management? J Andreani, J Lupo, R Germi, C Laugier, M Roccon, S Larrat, P Morand, ... Journal of Clinical Virology 143, 104947 , 2021 2021 Citations: 14
Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: influence of initial severity and steroid use O Epaulard, M Buisson, B Nemoz, M Le Maréchal, N Terzi, JF Payen, ... The Journal of Infection 84 (3), 418 , 2021 2021 Citations: 11
Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study T Semenova, B Nemoz, V Thibault, G Lagathu, G Duverlie, E Brochot, ... Epidemiology & Infection 147, e234 , 2019 2019 Citations: 11
New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases B Nemoz, D Ternant, S Bailly, E Gautier‐Veyret, JF Jourdil, B Bonaz, ... British Journal of Clinical Pharmacology 85 (4), 722-728 , 2019 2019 Citations: 10
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants L Dépéry, I Bally, A Amen, B Nemoz, M Buisson, L Grossi, A Truffot, ... Microbiology Spectrum 13 (1) , 2025 2025 Citations: 8
COVID-19 in clinical practice: A narrative synthesis M Le Marechal, P Morand, O Epaulard, B Nemoz Medecine et Maladies Infectieuses 50 (8), 639-647 , 2020 2020 Citations: 7
Risk factors for nosocomial COVID-19 in a French university hospital C Dinh, M Gallouche, H Terrisse, K Gam, C Giner, B Nemoz, S Larrat, ... Infectious Diseases Now 53 (5), 104695 , 2023 2023 Citations: 5
COVID-19 geographical maps and clinical data warehouse PREDIMED S Artemova, A Caporossi, C Cancé, PE Madiot, B Nemoz, S Larrat, ... MEDINFO 2021: One World, One Health–Global Partnership for Digital … , 2022 2022 Citations: 2
Measles-associated pneumonia in an immunocompromised patient: Persistent shortcomings in vaccination guidelines A Portais, M Le Marechal, B Nemoz, A Dartevel, G Rigault, P Pavese, ... Infectious Diseases Now 51 (3), 316-318 , 2021 2021 Citations: 2
Norcarfentanil, un métabolite d’intérêt dans le diagnostic toxicologique: à propos de 3 hospitalisations H Eysseric, N Allibe, NF Sam-Laï, M Bartoli, R Bruyère, D Protar, ... Toxicologie Analytique et Clinique 30 (2), S48-S49 , 2018 2018 Citations: 2
Use of RT-PCR thermocycling program for the quantification of DNA viruses in a single run with RNA viruses: example of Altona RealStar® HSV or VZV PCR kits J Andreani, J Lupo, B Nemoz, A Truffot, S Larrat, P Morand, R Germi Infectious Diseases Now , 2022 2022 Citations: 1
Risk factors of nosocomial Covid-19 in a French university hospital: a case-control study C Dinh, M Gallouche, H Terrisse, K Gam, C Giner, B Nemoz, S Larrat, ... 2022 Citations: 1
